{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:53:40Z","timestamp":1790229220018,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NSF","award":["DMR-1410987"],"award-info":[{"award-number":["DMR-1410987"]}]},{"DOI":"10.13039\/100007289","name":"Purdue Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jconrel.2017.08.007","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T19:00:41Z","timestamp":1502132441000},"page":"133-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages"],"prefix":"10.1016","volume":"267","author":[{"given":"Yihua","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed F.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-7701","authenticated-orcid":false,"given":"Yoon","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.08.007_bb0015","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2174\/1381612821666150310102702","article-title":"Antimicrobial peptides and peptidomimetics - potent therapeutic allies for staphylococcal infections","volume":"21","author":"Mohammad","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0020","doi-asserted-by":"crossref","first-page":"e0133877","DOI":"10.1371\/journal.pone.0133877","article-title":"Repurposing clinical molecule ebselen to combat drug resistant pathogens","volume":"10","author":"Thangamani","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0025","doi-asserted-by":"crossref","first-page":"373S","DOI":"10.1378\/chest.119.2_suppl.373S","article-title":"Hospital-acquired pneumonia: risk factors, microbiology, and treatment","volume":"119","author":"Lynch","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0030","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0035","doi-asserted-by":"crossref","first-page":"S378","DOI":"10.1086\/533594","article-title":"Pneumonia caused by methicillin-resistant staphylococcus aureus","volume":"46","author":"Rubinstein","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0040","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/313440","article-title":"Bacteremic pneumonia due to staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms","volume":"29","author":"Gonzalez","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature16057","article-title":"Novel antibody-antibiotic conjugate eliminates intracellular S. aureus","volume":"527","author":"Lehar","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0050","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/jac\/38.5.865","article-title":"Penetration of vancomycin into human lung tissue","volume":"38","author":"Cruciani","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/AAC.37.2.281","article-title":"Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients","volume":"37","author":"Lamer","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0060","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1086\/519470","article-title":"Limitations of vancomycin in the management of resistant staphylococcal infections","volume":"45","author":"Kollef","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0065","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.20160334","article-title":"Identification and treatment of the Staphylococcus aureus reservoir in vivo","author":"Surewaard","year":"2016","journal-title":"JEM"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijantimicag.2010.10.011","article-title":"Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant staphylococcus aureus (MRSA)","volume":"37","author":"Pumerantz","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0075","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/jac\/dks212","article-title":"Liposomal encapsulation of vancomycin improves killing of methicillin-resistant staphylococcus aureus in a murine infection model","volume":"67","author":"Sande","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0080","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1163\/092050611X570644","article-title":"Nano-hydroxyapatite\/chitosan\/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against staphylococcus aureus biofilms","volume":"22","author":"Ma","year":"2011","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0085","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/jac\/dkh465","article-title":"Treatment of experimental osteomyelitis by liposomal antibiotics","volume":"54","author":"Kadry","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0090","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0095","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3390\/polym7091488","article-title":"Preparation and evaluation of vancomycin-loaded n-trimethyl chitosan nanoparticles","volume":"7","author":"Xu","year":"2015","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0100","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0105","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1208\/s12249-008-9154-5","article-title":"Taste masking by spray-drying technique","volume":"9","author":"Bora","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1081\/DDC-120028716","article-title":"Formulation and in vitro evaluation of transdermal patches of melatonin","volume":"30","author":"Kanikkannan","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0115","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1021\/bm100481r","article-title":"Zwitterionic chitosan derivatives for pH-sensitive stealth coating","volume":"11","author":"Xu","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0120","series-title":"Phagocytosis of Polymer Microspheres by Macrophages, in: New Polymer Materials, Advances in Polymer Science","first-page":"107","volume":"Vol. 94","author":"Tabata","year":"1990"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2003.11.023","article-title":"Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms","volume":"271","author":"Leane","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0135","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/1061186X.2015.1054829","article-title":"Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel","volume":"23","author":"Abouelmagd","year":"2015","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0140","doi-asserted-by":"crossref","first-page":"9631","DOI":"10.1016\/S0021-9258(17)44543-1","article-title":"Activation of mouse peritoneal macrophages by lipopolysaccharide alters the kinetic parameters of the superoxide-producing NADPH oxidase","volume":"258","author":"Sasada","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0145","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1128\/AAC.02578-14","article-title":"Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides","volume":"58","author":"Mohamed","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0150","doi-asserted-by":"crossref","first-page":"29707","DOI":"10.1038\/srep29707","article-title":"Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus","volume":"6","author":"Mohamed","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0155","series-title":"Dual Targeting of Intracellular Pathogenic Bacteria with a Cleavable Conjugate of Kanamycin and an Antibacterial Cell-Penetrating Peptide","author":"Brezden","year":"2016"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0160","series-title":"Glycopeptide Antibiotics","article-title":"Glycopepides classification, occurrence, and discovery","author":"Yao","year":"1994"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0165","series-title":"Intermolecular and Surface Forces","first-page":"291","article-title":"Chapter 14 - electrostatic forces between surfaces in liquids","author":"Israelachvili","year":"2011"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0170","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1073\/pnas.0812588106","article-title":"Urea, but not guanidinium, destabilizes proteins by forming hydrogen bonds to the peptide group","volume":"106","author":"Lim","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.idc.2008.10.002","article-title":"Staphylococcus aureus: a community pathogen","volume":"23","author":"Miller","year":"2009","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2014.05.054","article-title":"Characterization of lysosome-destabilizing DOPE\/PLGA nanoparticles designed for cytoplasmic drug release","volume":"471","author":"Chhabra","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0190","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1242\/jcs.066399","article-title":"Breaking down the barriers: siRNA delivery and endosome escape","volume":"123","author":"Dominska","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0195","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nmeth.2998","article-title":"Protein delivery into live cells by incubation with an endosomolytic agent","volume":"11","author":"Erazo-Oliveras","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2017.08.007_bb0200","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/978-1-60761-919-2_37","article-title":"Application of a fusiogenic peptide GALA for intracellular delivery","volume":"683","author":"Nakase","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0205","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.addr.2003.10.041","article-title":"GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery","volume":"56","author":"Li","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.08.007_bb0210","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1021\/mp500389v","article-title":"Targeted delivery of doxorubicin by folic acid-decorated dual functional nanocarrier","volume":"11","author":"Lu","year":"2014","journal-title":"Mol. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917307745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917307745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T17:25:12Z","timestamp":1659288312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917307745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":40,"alternative-id":["S0168365917307745"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.08.007","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}